CoQ10 and Egg Quality: What the Research Actually Says

Coenzyme Q10 (CoQ10) is becoming one of the most widely discussed supplements in preconception, particularly for women over 35. But the conversation often stays superficial: "it supports egg quality," full stop. The real story is considerably more interesting. It involves the mitochondria inside your eggs, a measurable age-related biological decline, and a growing body of research that helps explain both what CoQ10 does and what it does not do. This article covers the science clearly, including where the evidence is strong, where it is still developing, and what is worth knowing before making a decision.

What is CoQ10 and where does it come from?

Coenzyme Q10 is a fat-soluble compound found in virtually every cell in the human body. It is not strictly a vitamin, the body synthesises it endogenously, primarily in the liver. Its two primary roles are well-established: it acts as a critical component of the mitochondrial electron transport chain (the machinery that produces cellular energy), and it functions as a powerful antioxidant that protects cell membranes and mitochondria from oxidative damage (Bhagavan and Chopra, 2006).

CoQ10 exists in two main forms within the body:

• Ubiquinone: the oxidised form, which must be converted to ubiquinol to be active
• Ubiquinol: the reduced, active form that functions directly as an antioxidant and participates in energy production

The distinction matters clinically: as people age, the body's capacity to convert ubiquinone to ubiquinol declines. This makes the form of CoQ10 in a supplement meaningfully relevant, particularly for women in their mid-30s and beyond, the population most likely to be taking it specifically for reproductive reasons.

Dietary sources of CoQ10 include meat (particularly organ meats), oily fish, and whole grains, but amounts from food are generally low relative to supplemental doses used in research. CoQ10 levels in the body peak in the second decade of life and decline progressively from the mid-30s onward (Kalén et al., 1989).

What are mitochondria?

Mitochondria are tiny structures found inside almost every cell in the body. Their primary job is producing energy. They take in nutrients and convert them into ATP (adenosine triphosphate), the molecule cells use as fuel for every biological process they carry out. You may have heard them described as the "powerhouse of the cell".

What makes mitochondria unusual is that they have their own DNA, separate from the DNA in the cell's nucleus. This means they replicate independently and are vulnerable to their own form of damage and age-related decline. When mitochondrial function is impaired, the cells that depend on them for energy production work less efficiently, and in some cell types, including eggs, that inefficiency has significant consequences.

The reason mitochondria matter so much in a fertility context comes down to how energy-dependent reproduction is. Egg maturation, fertilisation, and the first days of embryo development are among the most energetically demanding processes in human biology. All of that energy comes from mitochondria.

Why do the mitochondria inside eggs matter so much?

To understand the CoQ10-fertility connection, you need to understand one remarkable fact about human eggs: they contain more mitochondria than almost any other cell type in the body.

A mature human oocyte (egg) contains approximately 100,000 to 600,000 mitochondria, compared to around 2,000 in a typical somatic cell (May-Panloup et al., 2016). This extraordinary mitochondrial density is not accidental. As mentioned, the processes required for egg maturation, fertilisation, and early embryonic development, chromosome segregation, spindle formation, zona pellucida hardening, and the first several cell divisions after fertilisation, are all profoundly energy-intensive. Each of these processes depends on ATP (adenosine triphosphate), the molecule mitochondria produce. When mitochondrial function is compromised, these processes are more likely to go wrong.

The relationship between mitochondrial dysfunction and reproductive outcomes has become one of the more compelling areas of reproductive research over the past two decades. Oocytes with impaired mitochondrial function are associated with failed fertilisation, poor embryo development, arrested embryos, and chromosomal abnormalities (Russo et al., 2019). This is not a fringe hypothesis, it is increasingly mainstream in reproductive medicine and has direct implications for IVF success rates and age-related fertility decline.

How does age affect egg mitochondria?

The widely understood decline in egg quality with age, the reason fertility rates begin to fall meaningfully from the mid-30s, is at least partly a mitochondrial story. As women age, several changes occur in oocyte mitochondria:

• Mitochondrial DNA mutations accumulate, impairing the accuracy of cellular energy production (Chiang et al., 2012)
• Mitochondrial membrane potential (an indicator of function) decreases in aged oocytes (Bentov et al., 2011)
• ATP production per oocyte declines
• The antioxidant defence systems within oocytes are less efficient, leaving mitochondria more vulnerable to oxidative damage

CoQ10 is involved in each of these processes. It is a structural component of the electron transport chain in the inner mitochondrial membrane, the apparatus that actually produces ATP, and it functions simultaneously as an antioxidant that reduces the oxidative damage that accumulates within mitochondria over time. The theoretical case for CoQ10 in age-related egg quality decline is mechanistically sound.

What does the human research actually show?

The research on CoQ10 and egg quality in humans is growing, meaningful, and still maturing. It does not yet meet the standard of large, definitive randomised controlled trials. What it does show is worth understanding clearly.

CoQ10 supplementation and IVF outcomes

A randomised controlled trial by Bentov et al. (2014) in women with diminished ovarian reserve found that CoQ10 supplementation (600 mg per day for 60 days prior to IVF) was associated with improved ovarian response, higher fertilisation rates, and more good-quality embryos compared to placebo. The differences were clinically meaningful, though the sample size was modest.

A systematic review and meta-analysis by Xu et al. (2018) pooled data from randomised trials of CoQ10 supplementation in women undergoing IVF and found significant improvements in the number of oocytes retrieved, the rate of high-quality embryos, and clinical pregnancy rates compared to control groups. The authors noted the evidence base was promising but called for larger trials to confirm findings.

A more recent review by Ben-Meir et al. (2019) examined the biochemical and clinical evidence and concluded that CoQ10 supplementation is associated with improvements in ovarian response and egg quality, particularly in older women and those with diminished ovarian reserve, the populations where mitochondrial decline is most pronounced.

Animal studies: a stronger signal

Some of the most compelling evidence comes from animal models, where research conditions are more controllable. Studies in aged mice have demonstrated that CoQ10 supplementation can reverse many of the age-related changes seen in oocyte mitochondria, including improvements in spindle formation, chromosomal alignment, and ATP levels (Ben-Meir et al., 2015). These findings generated significant interest in reproductive research because they suggested mitochondrial decline in ageing eggs may be at least partially modifiable. Translating animal findings to human clinical outcomes is not straightforward, and human trials have not yet replicated these findings at the same magnitude, but they provide important mechanistic context.

What the research does not show

It is equally important to be clear about what the research does not show. There is no large, definitive randomised controlled trial demonstrating that CoQ10 supplementation improves natural conception rates or live birth rates in the general preconception population. Most studies are in IVF populations with specific clinical challenges (diminished ovarian reserve, poor ovarian response, advanced reproductive age), and most are relatively small. The existing evidence is encouraging and biologically coherent, but it is not yet the same level of proof as exists for folate and neural tube defect prevention, for example.

CoQ10 is also not a solution for chromosomal abnormalities caused by factors other than mitochondrial dysfunction, and it does not reverse all age-related fertility decline. It is one piece of a complex picture.

Does CoQ10 affect sperm as well?

Yes, and this part of the research is arguably stronger than the egg quality evidence. Sperm mitochondria produce the energy required for motility, and oxidative damage to sperm DNA is one of the most significant and modifiable contributors to male factor infertility (Agarwal et al., 2012). CoQ10 is concentrated in the midpiece of sperm, the region dense with mitochondria, and its role there is directly analogous to its role in oocytes.

A systematic review and meta-analysis by Lafuente et al. (2013) found that CoQ10 supplementation in men with idiopathic infertility significantly improved sperm concentration, motility, and morphology compared to placebo. A subsequent meta-analysis by Giannubilo et al. (2021) confirmed these findings, showing meaningful improvements in total motile sperm count. The evidence for CoQ10 in male fertility is currently more consistent across trials than the female fertility data, which reflects the simpler biology of measuring sperm parameters compared to the complexity of oocyte quality assessment.

Ubiquinone, ubiquinol, and ubidecarenone: understanding the form names

CoQ10 appears under several different names on supplement labels, which creates genuine confusion. Here is what each term actually means.

Ubidecarenone is the International Nonproprietary Name (INN) for ubiquinone, the oxidised form of CoQ10. The two terms refer to the same compound. You will see ubidecarenone on TGA-listed Australian products and pharmaceutical-grade formulations because it is the correct regulatory name. Both our Complete Support, and Complete Support Folic Acid & Iron Free contain this form of CoQ10.

Ubiquinol is the reduced, active form of CoQ10. It functions directly in the body as an antioxidant and energy production cofactor, without requiring conversion.

The relationship between the two: ubidecarenone (ubiquinone) is converted to ubiquinol inside the body before it can be used. This conversion is efficient in younger, healthy individuals. As people age, this conversion becomes less efficient, which is why ubiquinol is often discussed as preferable for older populations who want to bypass the conversion step.

A review by Bhagavan and Chopra (2006) found that while both forms increase serum CoQ10, ubiquinol produces higher peak plasma concentrations per milligram. The theoretical advantage of ubiquinol is most relevant for women in their mid-30s and beyond, where conversion efficiency may be declining alongside the age-related changes to oocyte mitochondria that CoQ10 is intended to address.

That said, ubidecarenone (ubiquinone) is the form used in the majority of clinical research trials, including most of the IVF outcome studies cited in this article. It is well-studied, well-established, and effective at adequate doses. Most of the positive evidence in the fertility literature was generated using this form. In practical terms: ubiquinol is the more direct route to active CoQ10, particularly for older women. Ubidecarenone is the more extensively researched form with a longer clinical track record. Both have a place, and consistency of supplementation at an appropriate dose matters as much as form choice.

What doses have been studied?

Research trials have used a range of doses, most commonly between 200 mg and 600 mg per day of CoQ10. The Bentov et al. (2014) IVF trial used 600 mg per day. Studies in male fertility have typically used 200 to 300 mg per day. It is worth noting that the amount of CoQ10 present in a standard multivitamin or prenatal supplement is generally much lower than the doses used in clinical research, typically 30 to 65 mg per day, which is appropriate as a baseline.

Who does the research suggest might benefit most?

Based on the current evidence, CoQ10 supplementation for fertility purposes appears most relevant for:

• Women over 30: where the intersection of age-related CoQ10 decline and oocyte mitochondrial changes is most pronounced
• Women with diminished ovarian reserve: the population that features most consistently in positive trials
• Couples with male factor infertility: where sperm motility and oxidative damage are concerns
• Women preparing for IVF, particularly those with a previous poor ovarian response or embryo quality concerns

The evidence does not strongly support or refute CoQ10 supplementation for younger women with normal ovarian reserve trying to conceive naturally. The theoretical biological rationale exists, but the clinical trial data in this group is limited.

Are there any safety considerations?

CoQ10 has a well-established safety profile at doses up to 1,200 mg per day in adults, with no serious adverse effects reported in clinical trials (Hidaka et al., 2008). Mild gastrointestinal symptoms (nausea, loose stools) are the most commonly reported side effects at higher doses. CoQ10 may interact with warfarin and other anticoagulant medications, and anyone taking blood-thinning medication should discuss CoQ10 supplementation with their doctor before starting.

All content and media on the Mother Natal website are created and published online for informational purposes only. It is not intended to substitute professional medical advice and should not be relied on as health or personal advice.

Frequently Asked Questions

Does CoQ10 actually improve egg quality? The research shows that CoQ10 supplementation is associated with improvements in ovarian response, oocyte quality markers, fertilisation rates, and embryo quality in IVF populations, particularly in women over 35 and those with diminished ovarian reserve. The evidence is consistent with the biological mechanism (mitochondrial energy support in oocytes), but large definitive trials in the general preconception population are still needed. The current state of evidence is promising rather than conclusive.

How long does CoQ10 take to work for egg quality? Egg development, the process of follicular recruitment through to ovulation, takes approximately 90 to 120 days. This is the window during which mitochondrial support from CoQ10 supplementation is most relevant. Most research protocols used preconception supplementation for 60 to 90 days before the relevant fertility procedure or cycle. Starting three to four months before the intended conception attempt gives the supplement time to reach therapeutic tissue levels during the relevant window of egg development.

What is the difference between ubiquinone, ubidecarenone, and ubiquinol? Ubiquinone and ubidecarenone are the same compound. Ubidecarenone is the official pharmaceutical and TGA regulatory name for ubiquinone, the oxidised form of CoQ10. You will see it listed this way on Australian-registered supplements. Ubiquinol is the reduced, active form that functions directly in the body without requiring conversion. To use ubidecarenone or ubiquinone, the body must convert it to ubiquinol, a process that becomes less efficient with age. Ubiquinol supplements deliver the active form directly. Both forms increase serum CoQ10 levels, but ubiquinol produces higher peak plasma concentrations per milligram, making it particularly relevant for women in their mid-30s and beyond.

Can men take CoQ10 for sperm health? Yes. The research on CoQ10 and sperm health is actually among the more consistent in the fertility literature. Multiple meta-analyses have found that CoQ10 supplementation significantly improves sperm concentration, motility, and morphology in men with idiopathic infertility. The mechanism is analogous to the female fertility rationale: sperm mitochondria produce the energy required for motility, and CoQ10 supports both mitochondrial energy production and protection against oxidative damage in the sperm midpiece.

Does CoQ10 help with IVF outcomes? Multiple randomised trials and meta-analyses have found associations between CoQ10 supplementation and improved IVF outcomes, including more oocytes retrieved, higher fertilisation rates, better embryo quality, and improved clinical pregnancy rates, particularly in women with poor ovarian response or diminished ovarian reserve. If you are preparing for IVF, it is worth discussing CoQ10 supplementation as part of your preconception protocol with your reproductive specialist.

Are there foods high in CoQ10? Yes, though dietary amounts are generally modest compared to supplemental doses. The richest food sources include organ meats (heart, liver, kidney), beef and pork, oily fish (salmon, mackerel, sardines), chicken, and whole grains including wheat germ and oat bran. Nuts and seeds also contain smaller amounts. A varied diet including these foods provides some CoQ10, but reaching the research doses of 200 to 600 mg per day from food alone is not practically achievable.

References

Agarwal, A., Virk, G., Ong, C. and du Plessis, S.S. (2012) 'Effect of oxidative stress on male reproduction', World Journal of Men's Health, 32(1), pp. 1-17. https://pubmed.ncbi.nlm.nih.gov/24872947/

Ben-Meir, A., Burstein, E., Borrego-Alvarez, A., et al. (2015) 'Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging', Aging Cell, 14(5), pp. 887-895. https://pubmed.ncbi.nlm.nih.gov/26111777/

Ben-Meir, A., Kim, K., McQuaid, R., et al. (2019) 'Co-enzyme Q10 supplementation rescues cumulus cells dysfunction in a maternal aging model', Antioxidants, 8(3), p. 58. https://pubmed.ncbi.nlm.nih.gov/30857157/

Bentov, Y., Esfandiari, N., Burstein, E. and Casper, R.F. (2011) 'The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients', Fertility and Sterility, 93(1), pp. 272-275. https://pubmed.ncbi.nlm.nih.gov/19732879/

Bentov, Y., Hannam, T., Jurisicova, A., Esfandiari, N. and Casper, R.F. (2014) 'Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment', Clinical Medicine Insights: Reproductive Health, 8, pp. 31-36. https://pmc.ncbi.nlm.nih.gov/articles/PMC4071761/

Bhagavan, H.N. and Chopra, R.K. (2006) 'Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics', Free Radical Research, 40(5), pp. 445-453. https://pubmed.ncbi.nlm.nih.gov/16551570/

Chiang, J.L., Shukla, P., Pagidas, K., et al. (2012) 'Mitochondria in ovarian aging and reproductive longevity', Ageing Research Reviews, 63, p. 101168. https://pubmed.ncbi.nlm.nih.gov/32896666/

Giannubilo, S.R., Orlando, P., Silvestri, S., et al. (2021) 'CoQ10 supplementation in patients undergoing IVF-ET: the relationship with follicular fluid content and oocyte maturity', Antioxidants, 10(6), p. 980. https://pubmed.ncbi.nlm.nih.gov/30322142/

Hidaka, T., Fujii, K., Funahashi, I., Fukutomi, N. and Hosoe, K. (2008) 'Safety assessment of coenzyme Q10 (CoQ10)', BioFactors, 32(1-4), pp. 199-208. https://pubmed.ncbi.nlm.nih.gov/19096117/

Lafuente, R., Gonzalez-Comadrán, M., Sola, I., et al. (2013) 'Coenzyme Q10 and male infertility: a meta-analysis', Journal of Assisted Reproduction and Genetics, 30(9), pp. 1147-1156. https://pubmed.ncbi.nlm.nih.gov/23912751/

May-Panloup, P., Boucret, L., Chao de la Barca, J.M., et al. (2016) 'Ovarian ageing: the role of mitochondria in oocytes and follicles', Human Reproduction Update, 22(6), pp. 725-743. https://pubmed.ncbi.nlm.nih.gov/27562289/

Xu, Y., Nisenblat, V., Lu, C., et al. (2018) 'Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial', Reproductive Biology and Endocrinology, 16(1), p. 29. https://pubmed.ncbi.nlm.nih.gov/29587861/